Cost-Effectiveness Analysis of Monotherapy for Preeclampsia Patients at RSUD Sleman
Abstract
Background: Preeclampsia treatment if not treated immediately will cause seizures and even cause death. Rational treatment can be seen from the (outcome) therapy and costs. Pharmacoeconomic analysis can be used to see which drug is most effective in terms of therapeutic outcomes and the costs incurred to obtain that therapy.
Objective: This study aims to analyze the cost-effective antihypertensive monotherapy in preeclampsia patients.
Methods: The research was conducted at the Sleman Regional Hospital on inpatient preeclampsia patients for the 2021-2022 period. Retrospective data collection in the form of medical record data and financial administration. The effectiveness of therapy is calculated based on blood pressure and length of stay with ICER (Incremental Cost-Effectiveness Ratio) calculations.
Results: The description of the characteristics of preeclampsia patients at Sleman Regional Hospital is dominated by those aged 20-35 years, 23 patients (51%), without comorbidities, 39 patients (87%). The most widely used antihypertensive monotherapy was Nifedipine in 33 patients (73%). The cost effective monotherapy is Nifedipine, with an ICER value of Rp. 3,258 based on blood pressure and an ICER of -Rp. 6,041 based on LOS
Conclusion: Monotherapy that cost effective for hospitalized preeclampsia patients at Sleman Regional Hospital is Nifedipine.
References
Cunningham. Obstetri Williams . 24th ed. Jakarta: EGC; 2014.
Balgis B, Sumardiyono S, Handayani S. Hubungan Antara Prevalensi Hipertensi, Prevalensi Dm Dengan Prevalensi Stroke Di Indonesia (Analisis Data Riskesdas Dan Profil Kesehatan 2018). Jurnal Kesehatan Masyarakat (Undip). 2022 May 30;10(3):379–84.
Dinas Kesehatan Provinsi Jawa Tengah. Profil Kesehatan Provinsi Jawa Tengah. Jakarta; 2017.
Himpunan Kedokteran Feto Maternal. Pedoman Nasional Pelayanan Kedokteran “Diagnosis dan Tatalaksana Pre-Eklamsia.” 2016.
Jannah DM, Pambudi RS, Khusna K. Analisis Efektivitas Biaya Terapi Pengobatan Pasien Preeklampsia Di Rsud Dr. Moewardi Surakarta Tahun 2021. Jurnal Ilmiah Kefarmasian. 2021 Nov;4(2).
Andayani TMurti. Farmakoekonomi Prinsip dan Metodologi. Yogyakarta: Bursa Ilmu; 2013.
Utari D, Hasibuan H. Hubungan Usia Ibu Hamil Dengan Tingkat Kejadian Preeklampsia Di Rumah Sakit Umum Haji Medan. Jurnal Kedokteran Ibnu Nafis. 2022 Jun 27;11(1):84–7.
Srimulyawati T, Rohim A, Kartikasari A, Ekayani E. Hubungan Antara Usia Ibu Hamil Dengan Kejadian Preeklampsia Di Rumah Sakit Umum Daerah 45 Kuningan. Journal of Public Health Innovation. 2021 Jun 14;1(2):105–12.
Sudarman, Tendean H, Wagey W. Faktor-faktor yang Berhubungan dengan Terjadinya Preeklampsia . e-CliniC. 2021;9(1).
Rahmadani. Ilmu Kebidanan praktis. Jakarta: EGC; 2012.
Bánhidy F, Ács N, Puhó EH, Czeizel AE. Iron deficiency anemia: Pregnancy outcomes with or without iron supplementation. Nutrition. 2011 Jan;27(1):65–72.
Yana AU, Brata C, Irawati S. Studi Penggunaan Antihipertensi pada Pasien Preeklampsia Rawat Jalan di Poliklinik Rumah Sakit Ibu dan Anak Surabaya. Jurnal Kesehatan. 2023 Aug 30;14(2):319.
Murphy VE, Schatz M. Asthma in pregnancy: a hit for two. European Respiratory Review. 2014 Mar 1;23(131):64–8.
Saputri Ika, Susilowati. Analisis BiayaPenggunaan Nifedipin Dan Metildopa PadaPasien Preeklampsia. FAJR (Jurnal Riset Kefarmasian). 2023 Jun;1(2).
Chambali MA, Meylina L, Rusli R. Analisis Efektivitas Biaya Penggunaan Obat Antihipertensi pada Pasien Preeklampsia di RSUD Abdul Wahab Sjahranie Periode 2018. Proceeding of Mulawarman Pharmaceuticals Conferences. 2019 Oct 31;10:32–7.
Dipiro J.T., Wells B.G., Schwinghammer T.L. Pharmacotherapy Handbook. McGraw-Hill Education Companies. Inggris: Ninth Edit; 2015.
Meilyana F, Djais J, Garna H. Status Gizi Berdasarkan Subjective Global Assessment Sebagai Faktor yang Mempengaruhi Lama Perawatan Pasien Rawat Inap Anak. Sari Pediatr 2016;12(3):162. 2016;12(3):162.
Chambali MA, Meylina L, Rusli R. Analisis Efektivitas Biaya Penggunaan Obat Antihipertensi pada Pasien Preeklampsia di RSUD Abdul Wahab Sjahranie Periode 2018. Proceeding of Mulawarman Pharmaceuticals Conferences. 2019 Oct 31;10:32–7.
NICE. Hypertension in pregnancy: diagnosis and management . 2023.
Quitterer U, Fu X, Pohl A, Bayoumy KM, Langer A, AbdAlla S. Beta-Arrestin1 Prevents Preeclampsia by Downregulation of Mechanosensitive AT1-B2 Receptor Heteromers. Cell. 2019 Jan;176(1–2):318-333.e19.
Widiana Anjami, Piter. Analisis Efektivitas Biaya Penggunaan Obat Antihipertensi Pada Pasien Preeklampsia Di Rumah Sakit Islam Jakarta Tahun 2017-2018 . Social Clinical Pharmacy Indonesia Journal. 2019;4(2):19–23.
Safitri WW, Dewi R, Sutrisno D. Analisis Efektivitas Biaya Penggunaan Metildopa Dibandingkan Dengan Nifedipine Pada Pasien Preeklampsia Rawat Inap Di RSUD H. Abdul Manap Kota Jambi. Jurnal Farmasi Udayana. 2021 Dec 31;126.
Garovic VD, Dechend R, Easterling T, Karumanchi SA, McMurtry Baird S, Magee LA, et al. Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association. Hypertension. 2022 Feb;79(2).
Winata GS, Setiawan WA, Pradnyana, Aroean M. The Role Of Antihypertensive Drugs In Patients With Preeclampsia Andhow To Prevent It: A Review Article. International Journal of Innovation Scientific Research and Review. 2022;04(10):3494–8.
Shubha Singhal, Anita K. Gupta, Vandana Ro. Cost Effectiveness of Labetalol Versus Methyldopa in The Treatment of Pregnancy Induced Hypertension (PIH). International Journal of Biological & Pharmaceutical Research. 2018;9(3):79–85.
Copyright (c) 2023 MEDIA ILMU KESEHATAN
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Articles received and published by the Media Ilmu Kesehatan are by the publication, the copyright of the article is fully transferred to the Media Ilmu Kesehatan. All operational forms such as printing, publication, and distribution of hard file journals are carried out by the Media Ilmu Kesehatan. Articles that have finished the review process and have been declared accepted by the journal manager or editor will be asked to fill out a statement of submission of copyright by the journal secretary to the main author or correspondent author. The statement of transfer of copyright is signed with a seal and sent via email to journalmik2018@gmail.com and contacted the admin of the journal to be followed up on archiving. Journal managers and editors have the right to edit the manuscript according to the provisions of the writing rules in the Media Ilmu Kesehatan.
Articles that have been declared accepted either online through the author's account on the OJS website https://ejournal.unjaya.ac.id/index.php/mik or a letter of receipt of the article (LOA), as well as those that have been published on OJS are not allowed to be published in other journals, or proceedings. The number of authors with more than one and as the main author or designated as the correspondent writer must have coordinated with members of the research team. The order of the authors submitted in the article as the author of one, two, three and so on cannot be changed when the article is published unless an error occurs in the technical operation of the journal.
